PMID- 21924999
OWN - NLM
STAT- MEDLINE
DCOM- 20120125
LR  - 20110919
IS  - 1558-0520 (Electronic)
IS  - 0733-8635 (Linking)
VI  - 29
IP  - 4
DP  - 2011 Oct
TI  - The use of intravenous immunoglobulin in autoimmune bullous diseases.
PG  - 565-70
LID - 10.1016/j.det.2011.06.010 [doi]
AB  - Intravenous immunoglobulin (IVIG) has been shown to be effective in the treatment 
      of autoimmune blistering diseases and may be an option if disease is refractory 
      to conventional treatment. IVIG effectiveness appears to increase when 
      administered concurrently with a cytotoxic drug and used in multiple treatment 
      cycles (though a single cycle may give benefit). Tapering administration may 
      improve the duration of remission and subcutaneous injections may be an option. 
      This article provides an introduction to the make-up and use of IVIG, and reviews 
      previous studies.
CI  - Copyright (c) 2011 Elsevier Inc. All rights reserved.
FAU - Chee, Shien-Ning
AU  - Chee SN
AD  - Department of Dermatology, St George Hospital, Gray Street, Kogarah, Sydney, NSW 
      2217, Australia.
FAU - Murrell, Dedee F
AU  - Murrell DF
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20110803
PL  - United States
TA  - Dermatol Clin
JT  - Dermatologic clinics
JID - 8300886
RN  - 0 (Adrenal Cortex Hormones)
RN  - 0 (Dermatologic Agents)
RN  - 0 (Immunoglobulins, Intravenous)
RN  - 0 (Immunologic Factors)
SB  - IM
MH  - Adrenal Cortex Hormones/therapeutic use
MH  - Dermatologic Agents/therapeutic use
MH  - Female
MH  - Humans
MH  - Immunoglobulins, Intravenous/*therapeutic use
MH  - Immunologic Factors/*therapeutic use
MH  - Male
MH  - Randomized Controlled Trials as Topic
MH  - Skin Diseases, Vesiculobullous/*drug therapy
MH  - Treatment Outcome
EDAT- 2011/09/20 06:00
MHDA- 2012/01/26 06:00
CRDT- 2011/09/20 06:00
PHST- 2011/09/20 06:00 [entrez]
PHST- 2011/09/20 06:00 [pubmed]
PHST- 2012/01/26 06:00 [medline]
AID - S0733-8635(11)00118-5 [pii]
AID - 10.1016/j.det.2011.06.010 [doi]
PST - ppublish
SO  - Dermatol Clin. 2011 Oct;29(4):565-70. doi: 10.1016/j.det.2011.06.010. Epub 2011 
      Aug 3.